These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Immunohistochemical evaluation of metallothionein, Mcm-2 and Ki-67 antigen expression in tumors of the adrenal cortex. Szajerka A; Dziegiel P; Szajerka T; Zabel M; Winowski J; Grzebieniak Z Anticancer Res; 2008; 28(5B):2959-65. PubMed ID: 19031940 [TBL] [Abstract][Full Text] [Related]
23. Transformation in recurrent ovarian granulosa cell tumors: Ki67 (MIB-1) and p53 immunohistochemistry demonstrates a possible molecular basis for the poor histopathologic prediction of clinical behavior. Costa MJ; Walls J; Ames P; Roth LM Hum Pathol; 1996 Mar; 27(3):274-81. PubMed ID: 8600043 [TBL] [Abstract][Full Text] [Related]
24. [Significance of p53 protein expression and proliferative potential with MIB-1 on tumor recurrence of pituitary adenomas]. Miyagami M; Nakamura S No To Shinkei; 1998 Jan; 50(1):27-32. PubMed ID: 9493195 [TBL] [Abstract][Full Text] [Related]
26. DNA topoisomerase II alpha and Ki-67 in human adrenocortical neoplasms: a possible marker of differentiation between adenomas and carcinomas. Iino K; Sasano H; Yabuki N; Oki Y; Kikuchi A; Yoshimi T; Nagura H Mod Pathol; 1997 Sep; 10(9):901-7. PubMed ID: 9310953 [TBL] [Abstract][Full Text] [Related]
27. Adrenal cortical neoplasms in the pediatric population: a clinicopathologic and immunophenotypic analysis of 83 patients. Wieneke JA; Thompson LD; Heffess CS Am J Surg Pathol; 2003 Jul; 27(7):867-81. PubMed ID: 12826878 [TBL] [Abstract][Full Text] [Related]
29. p53 mutations in human adrenocortical neoplasms: immunohistochemical and molecular studies. Reincke M; Karl M; Travis WH; Mastorakos G; Allolio B; Linehan HM; Chrousos GP J Clin Endocrinol Metab; 1994 Mar; 78(3):790-4. PubMed ID: 8126158 [TBL] [Abstract][Full Text] [Related]
30. Appraisal of intratumoral microvessel density, MIB-1 score, DNA content, and p53 protein expression as prognostic indicators in patients with locally confined renal cell carcinoma. Gelb AB; Sudilovsky D; Wu CD; Weiss LM; Medeiros LJ Cancer; 1997 Nov; 80(9):1768-75. PubMed ID: 9351546 [TBL] [Abstract][Full Text] [Related]
31. Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance. Baretton GB; Diebold J; Christoforis G; Vogt M; Müller C; Dopfer K; Schneiderbanger K; Schmidt M; Löhrs U Cancer; 1996 Jan; 77(2):255-64. PubMed ID: 8625232 [TBL] [Abstract][Full Text] [Related]
32. Carcinoma of the ampulla of Vater associated with or without adenoma: a clinicopathologic analysis of 198 cases with reference to p53 and Ki-67 immunohistochemical expressions. Takashima M; Ueki T; Nagai E; Yao T; Yamaguchi K; Tanaka M; Tsuneyoshi M Mod Pathol; 2000 Dec; 13(12):1300-7. PubMed ID: 11144926 [TBL] [Abstract][Full Text] [Related]
33. Discerning malignancy in human adrenocortical neoplasms: utility of DNA flow cytometry and immunohistochemistry. Suzuki T; Sasano H; Nisikawa T; Rhame J; Wilkinson DS; Nagura H Mod Pathol; 1992 May; 5(3):224-31. PubMed ID: 1353877 [TBL] [Abstract][Full Text] [Related]
34. Subependymal giant cell astrocytoma: a clinicopathological study of 23 cases with special emphasis on proliferative markers and expression of p53 and retinoblastoma gene proteins. Sharma M; Ralte A; Arora R; Santosh V; Shankar SK; Sarkar C Pathology; 2004 Apr; 36(2):139-44. PubMed ID: 15203749 [TBL] [Abstract][Full Text] [Related]
35. [Diagnostic value of A103 and inhibin-alpha in adrenocortical tumors: an immunohistochemical study using tissue microarray techniques]. Zhang HY; Wang XJ; Liu WP; Jiang LL; Li GD; Guo J; Zhang YH Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):203-7. PubMed ID: 15256108 [TBL] [Abstract][Full Text] [Related]
36. Topoisomerase alpha II, retinoblastoma gene product, and p53: potential relationships with aggressive behavior and malignant transformation in recurrent respiratory papillomatosis. Gupta D; Holden J; Layfield L Appl Immunohistochem Mol Morphol; 2001 Mar; 9(1):86-91. PubMed ID: 11277421 [TBL] [Abstract][Full Text] [Related]
37. Analysis of histological and immunohistochemical patterns of benign and malignant adrenocortical tumors by computerized morphometry. Dalino Ciaramella P; Vertemati M; Petrella D; Bonacina E; Grossrubatscher E; Duregon E; Volante M; Papotti M; Loli P Pathol Res Pract; 2017 Jul; 213(7):815-823. PubMed ID: 28554744 [TBL] [Abstract][Full Text] [Related]
38. Leiomyosarcoma versus bizarre and cellular leiomyomas of the uterus: a comparative study based on the MIB-1 and proliferating cell nuclear antigen indices, p53 expression, DNA flow cytometry, and muscle specific actins. Amada S; Nakano H; Tsuneyoshi M Int J Gynecol Pathol; 1995 Apr; 14(2):134-42. PubMed ID: 8601525 [TBL] [Abstract][Full Text] [Related]
39. Telomerase activity is significantly enhanced in malignant adrenocortical tumors in comparison to benign adrenocortical adenomas. Mannelli M; Gelmini S; Arnaldi G; Becherini L; Bemporad D; Crescioli C; Pazzagli M; Mantero F; Serio M; Orlando C J Clin Endocrinol Metab; 2000 Jan; 85(1):468-70. PubMed ID: 10634426 [TBL] [Abstract][Full Text] [Related]
40. Observations on tumor and metastatic suppressor gene status in endometrial carcinoma with particular emphasis on p53. Ambros RA; Vigna PA; Figge J; Kallakury BV; Mastrangelo A; Eastman AY; Malfetano J; Figge HL; Ross JS Cancer; 1994 Mar; 73(6):1686-92. PubMed ID: 8156496 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]